Novartis, Arrowhead strike upto USD 2 billion deal for neuromuscular therapy license
September 17, 2025
- Merck gets USFDA Breakthrough Therapy Designation for Raludotatug deruxtecan for Platinum-Resistant Ovarian Cancer
- Areteia Therapeutics Reports P-III (EXHALE-4) Trial Data of Dexpramipexole to Treat Eosinophilic Asthma
- SC to hear plea on Transgender reservation in PG medical education on September 18
- Korean Beauty Stick For Wrinkles – Beautiful With Brains
Headlines
